5-tert-Butyl 2-ethyl 6-methyl-4-oxopyrazolo[1,5-a]pyrazine-2,5(4H)-dicarboxylate, 96%, 250mg

3,3,5-Trimethylcyclohexanone>98.0%(GC)500mL

4-Hydroxy-3-methoxycinnamic acid, 98.0%, 100g

Matraces de fondo redondo de tres bocas, bocas laterales, biselados, 500 ml, 29/32, 29/32, 1 unidad

3-(4-(2-Ethoxy-2-phenylethyl)piperazin-1-yl)-2-methyl-1-phenylpropan-1-one dihydrochloride, 95.0%, 1g

3-Benzyl-7-bromo-2-methoxyquinoline, 98%, 100mg

3,4-Dimethoxypyridine, 95.0%, 25g

(6R)-6-(Hydroxymethyl)morpholin-3-one, 98+%, 100mg

1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one, 97.0%, 100g

6-methoxy-2-(5-methyl-2-furanyl)-N-(1-methyl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinolinamine, 5mg

N-(1-Methyl-2-oxo-propyl)-acetamide, 98.0%, 25g

4-(3-Bromophenyl)-N-(2-chlorophenyl)thiazol-2-amine hydrobromide, 95.0%, 2g

tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate, 95.0%, 10g